April 2024

You are here:
  1. Home
  2. 2024
  3. April
Seminar at NIB, 24.04.2024 “In Situ sequencing applied to cancer”

In this presentation, we will explore the methodology and significance of analyzing In Situ Sequencing (ISS) data in thecontext of colorectal cancer liver metastasis (CRCLM) and glioblastoma (GBM) samples. ISS offers a powerful approachto investigate spatially resolved gene expression patterns within tissues, providing crucial insights into tumormicroenvironments and cellular interactions. We will discuss the principles…

Read article
Capsule of Oppurtunity

Iza Rozman, a young researcher at National Institute of Biology (NIB) gave on 11th of April 2024 an oral presentation to graduate and postgraduate students at the Faculty of Pharmacy about the NIB, namely the Department of Genetic Toxicology and Cancer Biology, the CutCancer project, and her career as a young researcher at the institute.…

Read article
2nd General Assembly meeting

The General Assembly met online on 15th of April 2024, focusing on the interim progress report and the upcoming technical review meeting. Members of the General Assembly discussed the upcoming progress report deadline of May 2024, emphasising the need for updated information on milestones, researchers, and risks. Details on financial reporting were also discussed. The…

Read article
SINGLE CELL & SPATIAL DISCOVERY SYMPOSIUM
,

๐’๐ข๐ง๐ ๐ฅ๐ž ๐‚๐ž๐ฅ๐ฅ & ๐’๐ฉ๐š๐ญ๐ข๐š๐ฅ ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ was co-organised by Labena Slovenia & 10x Genomics and was a highly engaging event attended by over 120 ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ข๐ฉ๐š๐ง๐ญ๐ฌ ๐ข๐ง-๐ฉ๐ž๐ซ๐ฌ๐จ๐ง and well ๐จ๐ฏ๐ž๐ซ 200 ๐จ๐ง๐ฅ๐ข๐ง๐ž, both joining from all over the world. ๐“๐ก๐ž ๐’๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ ๐Ÿ๐ž๐š๐ญ๐ฎ๐ซ๐ž๐ ๐š๐ฅ๐ฆ๐จ๐ฌ๐ญ 20 ๐๐ข๐Ÿ๐Ÿ๐ž๐ซ๐ž๐ง๐ญ ๐ข๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฌ๐ฉ๐ž๐š๐ค๐ž๐ซ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐š๐ง๐ ๐š๐œ๐š๐๐ž๐ฆ๐ข๐š ๐ข๐ง ๐ฆ๐ž๐๐ข๐œ๐š๐ฅ, ๐›๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐š๐ง๐ ๐ฆ๐จ๐ฅ๐ž๐œ๐ฎ๐ฅ๐š๐ซ…

Read article